Antibe Therapeutics Company Top Insiders
| ATBPF Stock | USD 0.22 0.00 0.00% |
Antibe Therapeutics employs about 37 people. The company is managed by 9 executives with a total tenure of roughly 87 years, averaging almost 9.0 years of service per executive, having 4.11 employees per reported executive. Examination of Antibe Therapeutics' management performance can provide insight into the company performance.
| Philip Stern Insider VP Communications |
| Ana Stegic Insider Director Operations |
Antibe |
Antibe Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.1642) % which means that it has lost $0.1642 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4013) %, meaning that it generated substantial loss on money invested by shareholders. Antibe Therapeutics' management efficiency ratios could be used to measure how well Antibe Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Antibe Therapeutics Workforce Comparison
Antibe Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 770. Antibe Therapeutics holds roughly 37.0 in number of employees claiming about 5% of equities under Health Care industry.
Antibe Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Antibe Therapeutics Price Series Summation is a cross summation of Antibe Therapeutics price series and its benchmark/peer.
Antibe Therapeutics Notable Stakeholders
An Antibe Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Antibe Therapeutics often face trade-offs trying to please all of them. Antibe Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Antibe Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Philip Stern | VP Communications | Profile | |
| Ana Stegic | Director Operations | Profile | |
| LLB JD | CEO and President | Profile | |
| MEng CFA | Chief Officer | Profile | |
| MBA MSc | Founder Chair | Profile | |
| MBA DO | Chief Officer | Profile | |
| David Vaughan | Chief Devel. Officer | Profile | |
| MBA MBA | Chief Officer | Profile | |
| Christina BBA | VP Relations | Profile |
About Antibe Therapeutics Management Performance
The success or failure of an entity such as Antibe Therapeutics often depends on how effective the management is. Antibe Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Antibe management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Antibe management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. Antibe Therapeutics is traded on OTC Exchange in the United States.
Antibe Therapeutics Workforce Analysis
Traditionally, organizations such as Antibe Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Antibe Therapeutics within its industry.Antibe Therapeutics Manpower Efficiency
Return on Antibe Therapeutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 677.3K | |
| Net Loss Per Executive | 2.8M | |
| Working Capital Per Employee | 39.2K | |
| Working Capital Per Executive | 161K |
Complementary Tools for Antibe Pink Sheet analysis
When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |